Literature DB >> 20335020

Actionable indicators for short and long term outcomes in rectal cancer.

Marjan Gort1, Renée Otter, John T M Plukker, Manda Broekhuis, Niek S Klazinga.   

Abstract

AIM OF THE STUDY: Although patient and tumour characteristics are the most important determinants for outcomes in rectal cancer care, actionable factors for improving these are still unclear. Therefore, the purpose of this study was to assess the impact of surgeon and hospital factors which can actually be influenced to improve on postoperative complications, disease-free survival (DFS) and relative survival (RS) in rectal cancer.
METHODS: For 819 curatively operated rectal cancer patients, staged I-III and diagnosed between 2001 and 2005, data were derived from the population-based Cancer Registry of the Comprehensive Cancer Centre North East and supplemented by medical record examination. (Multilevel) Logistic regression analysis was performed to examine the influence of relevant factors on postoperative complications and time from diagnosis to first treatment. Besides, Cox regression analysis for DFS and relative survival analysis was performed.
RESULTS: Postoperative complications were dependent on type of surgery (p=0.024) and hospital volume (p=0.029). DFS was mainly influenced by stage (p<0.001) and time to treatment (p=0.018). Actionable indicators related to RS were type of surgery (p=0.011) and time to treatment (p=0.048). Time to treatment was found to be related to co-morbidity (p=0.007), preoperative radiotherapy (p=0.003) and referral for operation (p=0.048). Nevertheless, 18.2% unexplained variation in time to treatment remained on hospital level.
CONCLUSIONS: We conclude that optimal outcomes for rectal cancer care can be achieved by focusing on early detection and timely diagnosis, as well as adequate choice and timeliness of treatment in hospitals with optimal logistics for rectal cancer patients. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20335020     DOI: 10.1016/j.ejca.2010.02.044

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  7 in total

1.  Time from colorectal cancer diagnosis to laparoscopic curative surgery-is there a safe window for prehabilitation?

Authors:  N J Curtis; M A West; E Salib; J Ockrim; A S Allison; R Dalton; Nader K Francis
Journal:  Int J Colorectal Dis       Date:  2018-03-25       Impact factor: 2.571

Review 2.  Conflicting Guidelines: A Systematic Review on the Proper Interval for Colorectal Cancer Treatment.

Authors:  Charlotte J L Molenaar; Loes Janssen; Donald L van der Peet; Desmond C Winter; Rudi M H Roumen; Gerrit D Slooter
Journal:  World J Surg       Date:  2021-04-03       Impact factor: 3.352

3.  Cancer diagnostic tools to aid decision-making in primary care: mixed-methods systematic reviews and cost-effectiveness analysis.

Authors:  Antonieta Medina-Lara; Bogdan Grigore; Ruth Lewis; Jaime Peters; Sarah Price; Paolo Landa; Sophie Robinson; Richard Neal; William Hamilton; Anne E Spencer
Journal:  Health Technol Assess       Date:  2020-11       Impact factor: 4.014

4.  Influence of hospital type on survival in stage IV colorectal cancer.

Authors:  Nobuaki Hoshino; Suguru Hasegawa; Koya Hida; Kenji Kawada; Ryosuke Okamura; Madoka Hamada; Yoshinori Munemoto; Yoshiharu Sakai; Masahiko Watanabe
Journal:  Int J Colorectal Dis       Date:  2016-06-03       Impact factor: 2.571

Review 5.  Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review.

Authors:  R D Neal; P Tharmanathan; B France; N U Din; S Cotton; J Fallon-Ferguson; W Hamilton; A Hendry; M Hendry; R Lewis; U Macleod; E D Mitchell; M Pickett; T Rai; K Shaw; N Stuart; M L Tørring; C Wilkinson; B Williams; N Williams; J Emery
Journal:  Br J Cancer       Date:  2015-03-31       Impact factor: 7.640

6.  Importance of diagnosis-to-treatment interval in newly diagnosed patients with diffuse large B-cell lymphoma.

Authors:  Masahiro Yoshida; Yosuke Nakaya; Katsujun Shimizu; Naoko Tatsumi; Minako Tsutsumi; Hoyuri Fuseya; Mirei Horiuchi; Takuro Yoshimura; Yoshiki Hayashi; Takafumi Nakao; Takeshi Inoue; Takahisa Yamane
Journal:  Sci Rep       Date:  2021-02-02       Impact factor: 4.379

7.  Does delaying curative surgery for colorectal cancer influence long-term disease-free survival? A cohort study.

Authors:  Stephanie Garcia-Botello; J Martín-Arevalo; C Cozar-Lozano; A Benitez-Riesco; D Moro-Valdezate; V Pla-Martí; A Espí-Macías
Journal:  Langenbecks Arch Surg       Date:  2021-07-11       Impact factor: 3.445

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.